What is the primary revenue source for Mangoceuticals (MGRX)?

According to the latest financial reports, the company's revenue is driven by its core business segments and operational services. You can explore the exact breakdown and proportions of each revenue stream using the interactive charts on this page.

How can I visualize and analyze MGRX's financial statements?

gkcal provides interactive Sankey diagrams and profit waterfall charts that map out Mangoceuticals's total revenue, cost of goods sold, operating expenses, and net income, making it easy to understand their business model and cash flow at a glance.

How Mangoceuticals Makes Money: MGRX Revenue Breakdown (2026)

Operations

Where did the money come from, and where was it spent?

Watch

Revenue declined year over year, putting pressure on the core business.

Operating margin declined by 604.12 percentage points year over year.

Revenue: USD 136.62K
Cost of revenue: USD 18.66K

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Operating marginLoss from operations · operating_income / revenue * 100
RevenueRevenues [default label] · Revenues
Cost of revenueCost of revenues · CostOfRevenue

The filing lacks sufficient revenue breakdown data to identify specific revenue sources.

Assets

Where is the money tied up, and how is the company financed?

Watch

Current assets do not cover near-term liabilities, indicating short-term funding pressure.

Cash and cash equivalents: USD 228.69K
Property, plant and equipment: USD 1.29K
Total liabilities: USD 1.65M
Shareholder equity: USD 12.52M

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Shareholder equityTotal stockholders’ equity · StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total liabilitiesTotal liabilities · Liabilities
Cash and cash equivalentsCash and cash equivalents · CashAndCashEquivalentsAtCarryingValue
Property, plant and equipmentProperty and equipment, net of accumulated depreciation of $3,770 and $3,268 · PropertyPlantAndEquipmentNet

Cash

Did accounting profit ultimately turn into cash?

Insufficient data

Current data explains this period's structure but is insufficient for a year-over-year conclusion.

Operating cash flow: USD −1.58M

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Operating cash flowsum(waterfull.operating)

Some conclusions lack complete source metrics and should be interpreted cautiously.

Capital expenditure data is missing, so free cash flow cannot be calculated.

Shareholders

Did the money earned actually make its way back to shareholders?

Watch

Share issuance proceeds exceeded dividends and repurchases, making the company a net equity raiser.

Stock issuance proceeds: USD 272.00K
Net shareholder return: USD −272.00K

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Net shareholder returndividends_paid + share_repurchases - stock_issuance_proceeds
Stock issuance proceedsGross proceeds · ProceedsFromIssuanceOfCommonStock · abs(node_value)

Diluted share count is missing, so dilution cannot be assessed against buybacks.

Financial Insights

Please select a report to view

Where did the money come from, and where was it spent?

Where is the money tied up, and how is the company financed?

Did accounting profit ultimately turn into cash?

Did the money earned actually make its way back to shareholders?